ARS Pharmaceuticals, Inc. SPRY Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $797.36M.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s market capitalization?
- ARS Pharmaceuticals, Inc. (SPRY) reported market capitalization of $797.36M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- ARS Pharmaceuticals, Inc.'s market capitalization decreased by 35.4% year-over-year, from $1.23B to $797.36M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s market capitalization has grown at a -6.5% compound annual growth rate (CAGR), from $1.61B to $1.15B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.